Mary Kay Ladone

This profile gathers the share dealings of Mary Kay Ladone across 5 companies, led by Bioventus Inc., Hill-Rom Holdings, Inc. and Inogen Inc. The record holds 23 filings, for trades running from 23 July 2021 to 9 September 2026.

The open-market record consists of 3 sales worth €1.0M, with no purchase. Outside the open market, there are 7 share grants and 12 option exercises. 2026 to date brings no purchases and 1 sale.

The record was last updated on 10 September 2026 with a share grant in Kestra Medical Technologies, Ltd. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.